DLHAX Holdings Information

DLHAX is a mutual fund with a total of 109 individual holdings. The top holdings are Regeneron Pharmaceuticals stock at 5.24%, UCB SA at 5.24%, Eli Lilly and Company at 4.35%, AbbVie at 4.13%, and Pfizer at 4.12%.

Total Holdings

109

Top 10 Percentage

41.28%

Asset Class

Equity

Fund Category

Health

Assets

687.21M

Forward PE Ratio

15.22

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	REGN	Regeneron Pharmaceuticals, Inc.	5.24%	47,000
2	EBR: UCB	UCB SA	5.24%	130,137
3	LLY	Eli Lilly and Company	4.35%	28,000
4	ABBV	AbbVie Inc.	4.13%	125,000
5	PFE	Pfizer Inc.	4.12%	1,145,000
6	MRK	Merck & Co., Inc.	4.11%	270,000
7	GILD	Gilead Sciences, Inc.	3.72%	210,000
8	LON: AZN	AstraZeneca PLC	3.51%	131,243
9	BSX	Boston Scientific Corporation	3.44%	250,000
10	TYO: 4519	Chugai Pharmaceutical Co., Ltd.	3.41%	450,000
11	UNH	UnitedHealth Group Incorporated	3.34%	70,000
12	SWX: ROG	Roche Holding AG	3.28%	55,000
13	ELV	Elevance Health, Inc.	3.19%	63,000
14	AMGN	Amgen Inc.	2.74%	58,000
15	HALO	Halozyme Therapeutics, Inc.	2.14%	220,000
16	VTRS	Viatris Inc.	2.11%	1,170,018
17	FNMA	Federal National Mortgage Association Fannie Mae	2.02%	1,300,000
18	ALNY	Alnylam Pharmaceuticals, Inc.	1.72%	30,000
19	ILMN	Illumina, Inc.	1.71%	90,000
20	VKTX	Viking Therapeutics, Inc.	1.68%	330,100
21	EPA: SAN	Sanofi	1.68%	120,000
22	VRTX	Vertex Pharmaceuticals Incorporated	1.64%	25,000
23	FMCC	Federal Home Loan Mortgage Corp	1.54%	1,050,000
24	NBIX	Neurocrine Biosciences, Inc.	1.43%	70,000
25	RCUS	Arcus Biosciences, Inc.	1.31%	379,100

Showing 25 of 109 holdings

Subscribe to see the full list

Activate Now

As of Dec 31, 2025